NCCN Guidelines Insights: Breast Cancer, Version 3.2018.
Journal
Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
entrez:
22
2
2019
pubmed:
23
2
2019
medline:
22
7
2020
Statut:
ppublish
Résumé
These NCCN Guidelines Insights highlight the updated recommendations for use of multigene assays to guide decisions on adjuvant systemic chemotherapy therapy for women with hormone receptor-positive, HER2-negative early-stage invasive breast cancer. This report summarizes these updates and discusses the rationale behind them.
Identifiants
pubmed: 30787125
pii: insbr1702
doi: 10.6004/jnccn.2019.0009
doi:
pii:
Types de publication
Journal Article
Practice Guideline
Langues
eng
Sous-ensembles de citation
IM
Pagination
118-126Informations de copyright
Copyright © 2019 by the National Comprehensive Cancer Network.